Ownership and insider activity for GoodRx Holdings, Inc. (GDRX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States.
Price
| Price | $3.36 |
| Market Cap | $1.2B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-15 | Chan Thomas (TC) | M-Exempt | 2,101 | |
| 2026-09-15 | Chan Thomas (TC) | F-InKind | 1,069 | $4K |
| 2026-09-15 | Chan Thomas (TC) | M-Exempt | 2,101 | |
| 2026-09-15 | Fengler Justin | M-Exempt | 2,335 | |
| 2026-09-15 | Fengler Justin | M-Exempt | 752 | |
| 2026-09-15 | Fengler Justin | F-InKind | 330 | $1K |
| 2026-09-15 | Fengler Justin | F-InKind | 1,024 | $4K |
| 2026-09-15 | Fengler Justin | M-Exempt | 2,335 | |
| 2026-09-15 | Fengler Justin | M-Exempt | 752 | |
| 2026-08-24 | FRANCISCO PARTNERS IV, L.P. | S-Sale | 72,309 | $250K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.6M | $17.5M | $34.6M | $26.1M | $968.7M | $941.1M | $757.2M | $672.3M | $448.3M | $261.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | $35.0M | $55.5M | $97.3M | $126.4M | $121.7M | $160.0M | $160.8M | $254.9M |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 0 | 0 | $73.1M | $86.6M | $1.09B | $1.09B | $919.7M | $872.8M | $659.3M | $643.1M |
| Property, Plant & Equipment | 0 | 0 | $988,000 | $34.2M | $50.8M | $49.3M | $55.7M | $45.9M | $40.5M | $41.1M |
| Goodwill | 0 | 0 | $220.4M | $236.2M | $261.1M | $329.7M | $412.1M | $410.8M | $410.8M | $430.3M |
| Intangible Assets | 0 | 0 | $18.3M | $26.4M | $56.7M | $133.8M | $189.9M | $156.3M | $176.9M | $203.3M |
| Total Assets | $295.6M | $286.9M | $314.8M | $386.8M | $1.47B | $1.61B | $1.60B | $1.59B | $1.39B | $1.40B |
| Accounts Payable | 0 | 0 | $7.2M | $7.9M | $10.3M | $17.5M | $17.7M | $36.3M | $14.1M | $19.4M |
| Short-term Debt | 0 | 0 | $5.4M | $7.0M | $7.0M | $7.0M | $7.0M | $8.8M | $5.0M | $5.0M |
| Total Current Liabilities | 0 | 0 | $16.6M | $33.4M | $59.6M | $81.1M | $76.3M | $122.6M | $123.9M | $246.0M |
| Long-term Debt | $46.1M | $136.0M | $716.8M | $663.9M | $659.9M | $655.9M | $651.8M | $647.7M | $486.7M | $483.3M |
| Total Liabilities | $46.1M | $136.0M | $1.48B | $1.47B | $758.8M | $775.9M | $789.8M | $826.8M | $663.4M | $787.8M |
| Retained Earnings | $8.1M | -$86.2M | -$1.16B | -$1.10B | -$1.39B | -$1.42B | -$1.45B | -$1.46B | -$1.44B | -$1.41B |
| Total Equity | $8.1M | -$86.2M | -$1.16B | -$1.09B | $711.4M | $831.7M | $814.8M | $762.0M | $724.7M | $616.3M |
| Total Debt | $46.1M | $136.0M | $722.2M | $711.0M | $704.9M | $702.3M | $717.0M | $711.1M | $543.4M | $542.8M |
| Net Debt | $22.5M | $118.5M | $687.6M | $684.9M | -$263.8M | -$238.8M | -$40.1M | $38.8M | $95.0M | $281.0M |
| Working Capital | 0 | 0 | $56.5M | $53.2M | $1.03B | $1.01B | $843.4M | $750.2M | $535.4M | $397.1M |
Financial Health
| Debt / Equity | 0.83 |
| Current Ratio | 1.38 |
Profitability
| Return on Equity | 2.61% |
| Return on Invested Capital | 2.64% |
| Return on Assets | 0.69% |
| Gross Margin | 88.05% |
| Operating Margin | 10.25% |
| Net Margin | 2.07% |
Related companies: AHCO · AMPH · COLL · CTEV · HSTM · INVA · IRMD
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of GDRX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks